Celularity, Inc.   Report issue

For profit Phase 2
Founded: Florham Park NJ United States (2016)

Organization Overview

First Clinical Trial
2020
NCT04310592
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Celularity inc. | Celularity, Inc. | Celularity Incorporated